Bill Text: US SB1681 | 2017-2018 | 115th Congress | Introduced
Bill Title: A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.
Spectrum: Partisan Bill (Independent 1-0)
Status: (Introduced - Dead) 2017-07-31 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. [SB1681 Detail]
Download: US_Congress-2017-SB1681-Introduced.pdf